17Jan 2025
High-Dose IvitTopo Achieves Globe Salvage in Recurrent Retinoblastoma

High-Dose IvitTopo Achieves Globe Salvage in Recurrent Retinoblastoma

High-dose intravitreal topotecan (IvitTopo) effectively controlled recurrent retinoblastoma in 13 patients, achieving 92% tumor regression and 100% globe salvage. No complications occurred, indicating its safety and efficacy as an adjunct or potentially stand-alone therapy.

  • #ophthalmology

Like

Save

Share